Testing effectiveness (Phase 2)Study completedNCT01941745
What this trial is testing
Efficacy of Recombinant Human Clara Cell 10 Protein (rhCC10) Administered to Premature Neonates With Respiratory Distress Syndrome
Who this might be right for
Respiratory Distress Syndrome in Premature InfantBronchopulmonary Dysplasia
Tufts Medical Center 88